Urine Cytology and Utility in Bladder Recurrence
NCT00971256 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2011-11-23
Summary
Review bladder cancer patients and form a database in regards to urine cytology.
Conditions
Sponsors & Collaborators
-
William Beaumont Hospitals
lead OTHER
Principal Investigators
-
Joseph Mashni, MD · Beaumont Hospitals
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-09-30
- Primary Completion
- 2010-09-30
- Completion
- 2010-09-30
More Related Trials
-
Confocal Laser Endomicroscopy in the Lower Urinary Tract
NCT03013894 ·Status: COMPLETED
-
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health
NCT00776178 ·Status: COMPLETED
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Evaluating Bladder CARE™, a New Non-Invasive Urine Test, for Bladder Cancer Detection in Inconclusive Cases
NCT06870253 ·Status: ACTIVE_NOT_RECRUITING
-
Personalized Urine Biomarker for Patients With Bladder Cancer
NCT05467267 ·Status: UNKNOWN
-
Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma
NCT05979909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
NCT05796375 ·Status: RECRUITING ·Phase: PHASE2
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Outcome of Radiation Therapy in Urinary Bladder Squampus Cell Carcinoma
NCT04815629 ·Status: UNKNOWN
-
Molecular Analysis Of Bladder Cancer
NCT00871754 ·Status: ACTIVE_NOT_RECRUITING
-
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
NCT07029256 ·Status: RECRUITING
-
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
NCT02700464 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
NCT03125460 ·Status: COMPLETED
-
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
NCT03193515 ·Status: RECRUITING
-
Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma
NCT05139134 ·Status: UNKNOWN
-
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
NCT03013920 ·Status: COMPLETED
-
Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
NCT01731652 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
NCT03193541 ·Status: RECRUITING
-
Validation Study of Uromonitor in High Risk Microhematuria Patients
NCT05344937 ·Status: UNKNOWN
-
Study to Improve Detection and Early Recurrence Rate in Bladder Cancer Patients Using Hexvix Fluorescence Cystoscopy
NCT00233402 ·Status: COMPLETED ·Phase: PHASE3
-
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
NCT02647112 ·Status: COMPLETED ·Phase: NA
-
Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
NCT07251946 ·Status: COMPLETED
-
The Cxbladder Monitoring Study
NCT02700659 ·Status: COMPLETED
-
Bladder Cancer Detection Using Convolutional Neural Networks
NCT05193656 ·Status: RECRUITING